Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE-ABDO: Semuloparin vs Enoxaparin for VTE Prevention in Major Abdominal Surgery
NCT00679588Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2008
- Primary completion
- Aug 2010
- Modality
- Peptides, Small Molecules
- Countries
- 39
01
Overview
A Phase 3 trial of semuloparin in venous thromboembolism (VTE), sponsored by Sanofi. Started Apr 2008; status: completed.
02
Drugs
semuloparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00679588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679588.